Evaluation of the potential of small molecule therapy for a pharmaceutical client

A major pharmaceutical company wanted to assess whether a small-molecule therapeutic could compete with an antibody-based approach for preventing cytomegalovirus (CMV) infection in special patient populations across 7 major markets. GlobalData mapped clinical pathways for prevention, diagnosis and treatment, identified unmet needs, built an ideal therapeutic product profile (efficacy, safety, formulation, cost, compliance), and ran market forecasting with scenario analysis, including "40 KOL interviews in the US, Japan, and EU" plus secondary research. The engagement delivered clear unmet-need findings, product-uptake scenarios, and patient modeling/forecasting including specialty segments; no specific market-size figures are disclosed on the page.

GlobalData is a pipeline, clinical-trial and market-intelligence data provider, similar in kind to Cortellis, tracking hundreds of thousands of drugs across their full lifecycle.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.